Your browser doesn't support javascript.
loading
Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma.
Kankeu Fonkoua, Lionel A; Chakrabarti, Sakti; Sonbol, Mohamad B; Kasi, Pashtoon M; Starr, Jason S; Liu, Alex J; Nevala, Wendy K; Maus, Rachel L; Bois, Melanie C; Pitot, Henry C; Chandrasekharan, Chandrikha; Ross, Helen J; Wu, Tsung-Teh; Graham, Rondell P; Villasboas, Jose C; Weiss, Matthias; Foster, Nathan R; Markovic, Svetomir N; Dong, Haidong; Yoon, Harry H.
Affiliation
  • Kankeu Fonkoua LA; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Chakrabarti S; Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Sonbol MB; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kasi PM; Department of Oncology, Medical College of Wisconsin, Wauwatosa, Wisconsin, USA.
  • Starr JS; Department of Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Liu AJ; Department of Oncology, Mayo Clinic, Jacksonville, Florida, USA.
  • Nevala WK; Department of Oncology, University of Iowa, Iowa City, Iowa, USA.
  • Maus RL; Department of Oncology, Mayo Clinic, Jacksonville, Florida, USA.
  • Bois MC; Department of Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Pitot HC; Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Chandrasekharan C; Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.
  • Ross HJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Wu TT; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Graham RP; Department of Oncology, University of Iowa, Iowa City, Iowa, USA.
  • Villasboas JC; Department of Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Weiss M; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Foster NR; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Markovic SN; Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Dong H; Department of Immune Monitoring Core, Mayo Clinic, Rochester, Minnesota, USA.
  • Yoon HH; ThedaCare Cancer Care, Appleton, Wisconsin, USA.
Int J Cancer ; 149(2): 378-386, 2021 07 15.
Article in En | MEDLINE | ID: mdl-33739449
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Paclitaxel / Antibodies, Monoclonal, Humanized / Gastrointestinal Neoplasms / Immune Checkpoint Inhibitors Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Int J Cancer Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Paclitaxel / Antibodies, Monoclonal, Humanized / Gastrointestinal Neoplasms / Immune Checkpoint Inhibitors Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Int J Cancer Year: 2021 Document type: Article